ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.21
-0.29 (-1.29%)
Jun 26, 2025, 4:00 PM - Market closed
ACADIA Pharmaceuticals Employees
As of December 31, 2024, ACADIA Pharmaceuticals had 654 total employees, including 653 full-time and 1 part-time employees. The number of employees increased by 56 or 9.36% compared to the previous year.
Employees
654
Change (1Y)
56
Growth (1Y)
9.36%
Revenue / Employee
$1,523,369
Profits / Employee
$349,974
Market Cap
3.72B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACAD News
- 1 day ago - Acadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value Drivers - Business Wire
- 9 days ago - Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 17 days ago - U.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of Acadia in NUPLAZID® (pimavanserin) Composition of Matter Patent - Business Wire
- 21 days ago - Acadia Pharmaceuticals to Host R&D Day in New York City on June 25, 2025 - Business Wire
- 4 weeks ago - Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire
- 4 weeks ago - Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise - Business Wire
- 5 weeks ago - These Analysts Boost Their Forecasts On Acadia Pharmaceuticals - Benzinga
- 5 weeks ago - Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout Preview - Seeking Alpha